The effect of aerobic physical activity and cannabis powder consumption in sedentary young men

The effect of aerobic physical activity alone and in combination with hemp seed powder consumption on biophysical, metabolic and neurological parameters in sedentary young men

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140907019082N10

Enrollment

Registered

2021-02-20

Start date

2021-03-10

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary men.

Interventions

Intervention 1: Intervention group: People in the physical activity group with supplements, take 2 capsules of hemp seed powder a day, one before lunch and one the night before bed, and also work out

Eligibility

Sex/Gender

Male

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Male age 18-40 low active Inclination to participate in the study

Exclusion criteria

Exclusion criteria: Use any medication or diet and exercise supplements for at least 2 months before the start of the study Respiratory disease Cardiovascular disease and hypertension Diabetes Thyroid disease Nervous disease Skeletal muscle disease Autoimmune disease Skeletal and joint problems

Design outcomes

Primary

Measure	Time frame
Biophysical indicators (balance, strength, mental function). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: stabilometer, dynamometer, VTS.;Neurological factors BDNF and NPY. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Fasting Blood Glucose (FBG). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Laboratory evaluation.;Serum level of Insulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Lipid profile. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Laboratory evaluation.;Insulin resistance index. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Using formula.;Renal function indicators (total iron-binding capacity, creatinine, urea, uric acid). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Serum electrolytes (total iron-binding capacity, magnesium, iron, calcium, phosphorus). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;High-sensitivity C-reactive protein. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Liver function (ALT, AST, direct bilirubin, ALP, albumin, total bilirubin, total protein). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Lactate dehydrogenase activity. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Creatine kinase activity. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Testosterone. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Sex hormone binding globulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Oxidative stress status (MDA, SOD, GPX, TAC, Catalase). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.	—

Measure

Time frame

Biophysical indicators (balance, strength, mental function). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: stabilometer, dynamometer, VTS.;Neurological factors BDNF and NPY. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Fasting Blood Glucose (FBG). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Laboratory evaluation.;Serum level of Insulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Lipid profile. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Laboratory evaluation.;Insulin resistance index. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Using formula.;Renal function indicators (total iron-binding capacity, creatinine, urea, uric acid). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Serum electrolytes (total iron-binding capacity, magnesium, iron, calcium, phosphorus). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;High-sensitivity C-reactive protein. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Liver function (ALT, AST, direct bilirubin, ALP, albumin, total bilirubin, total protein). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Lactate dehydrogenase activity. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Creatine kinase activity. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Testosterone. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Sex hormone binding globulin. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.;Oxidative stress status (MDA, SOD, GPX, TAC, Catalase). Timepoint: Baseline and 8 weeks after intervention. Method of measurement: ELIZA.

—

Secondary

Measure	Time frame
Anthropometric indices. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: Seca Scale, stadiometer and strip meter.;Body composition. Timepoint: Baseline and 8 weeks after intervention. Method of measurement: With the body composition analyzer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Mohammad Rezaei

Tabriz University of Medical Sciences

alimrezaei4@gmail.com+98 41 3335 7580

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026